{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:08:21Z","timestamp":1793772501880,"version":"4.6.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This review article examines how stem cell therapies can cure various diseases and injuries while also discussing the difficulties and moral conundrums that come with their application. The article focuses on the revolutionary developments in stem cell research, especially the introduction of gene editing tools like CRISPR-Cas9, which can potentially improve the safety and effectiveness of stem cell-based treatments. To guarantee the responsible use of stem cells in clinical applications, it is also argued that standardizing clinical procedures and fortifying ethical and regulatory frameworks are essential first steps. The assessment also highlights the substantial obstacles that still need to be addressed, such as the moral dilemmas raised by the use of embryonic stem cells, the dangers of unlicensed stem cell clinics, and the difficulties in obtaining and paying for care for patients. The study emphasizes how critical it is to address these problems to stop exploitation, guarantee patient safety, and increase the accessibility of stem cell therapy. The review also addresses the significance of thorough clinical trials, public education, and policy development to guarantee that stem cell research may fulfill its full potential. The review concludes by describing stem cell research as a promising but complicated topic that necessitates a thorough evaluation of both the hazards and the benefits. To overcome the ethical, legal, and accessibility obstacles and eventually guarantee that stem cell treatments may be safely and fairly included in conventional healthcare, it urges cooperation between the scientific community, legislators, and the general public.<\/jats:p>","DOI":"10.1186\/s13287-025-04334-1","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:39:40Z","timestamp":1747906780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Stem cell therapy: a revolutionary cure or a pandora's box"],"prefix":"10.1186","volume":"16","author":[{"given":"Hany E.","family":"Marei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"4334_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"T Ja","year":"1998","unstructured":"Ja T. Embryonic stem cell lines, derived from human blastocysts. Science. 1998;282:1145\u20137.","journal-title":"Science"},{"issue":"4","key":"4334_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"key":"4334_CR3","volume-title":"James Till and Ernest McCulloch: The Team that Discovered Stem Cells","author":"E Thompson","year":"2020","unstructured":"Thompson E. James Till and Ernest McCulloch: The Team that Discovered Stem Cells. The Rosen Publishing Group, Inc; 2020."},{"issue":"1","key":"4334_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40\u201351.","journal-title":"Nat Biotechnol"},{"issue":"4142","key":"4334_CR5","first-page":"w13696","volume":"142","author":"JR Passweg","year":"2012","unstructured":"Passweg JR, Halter J, Bucher C, Gerull S, Heim D, Rov\u00f3 A, et al. Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner. Swiss Med Wkly. 2012;142(4142):w13696\u2013w13696.","journal-title":"Swiss Med Wkly"},{"issue":"10","key":"4334_CR6","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/eye.2008.379","volume":"23","author":"L Liang","year":"2009","unstructured":"Liang L, Sheha H, Li J, Tseng S. Limbal stem cell transplantation: new progress and challenges. Eye. 2009;23(10):1946\u201353.","journal-title":"Eye"},{"issue":"11","key":"4334_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32(11):1121\u201333.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"4334_CR8","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1242\/dev.092551","volume":"140","author":"K Takahashi","year":"2013","unstructured":"Takahashi K, Yamanaka S. Induced pluripotent stem cells in medicine and biology. Development. 2013;140(12):2457\u201361.","journal-title":"Development"},{"key":"4334_CR9","doi-asserted-by":"crossref","unstructured":"Moy AB, Kamath A, Ternes S, Kamath J. The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy. Med Res Arch. 2023;11(11).","DOI":"10.18103\/mra.v11i11.4784"},{"issue":"7","key":"4334_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/cells13070596","volume":"13","author":"C Sun","year":"2024","unstructured":"Sun C, Serra C, Kalicharan BH, Harding J, Rao M. Challenges and considerations of preclinical development for iPSC-based myogenic cell therapy. Cells. 2024;13(7):596.","journal-title":"Cells"},{"issue":"7244","key":"4334_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato T, Vries RG, Snippert HJ, Van De Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262\u20135.","journal-title":"Nature"},{"issue":"7","key":"4334_CR12","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modeling development and disease with organoids. Cell. 2016;165(7):1586\u201397.","journal-title":"Cell"},{"issue":"7467","key":"4334_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501(7467):373\u20139.","journal-title":"Nature"},{"issue":"6","key":"4334_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"G Schwank","year":"2013","unstructured":"Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, Demircan T, et al. Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell. 2013;13(6):653\u20138.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4334_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah A, Tan SH, Barker N. Organoids as an in vitro human development and disease model. Nat Cell Biol. 2016;18(3):246\u201354.","journal-title":"Nat Cell Biol"},{"issue":"7659","key":"4334_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature22796","volume":"546","author":"JG Camp","year":"2017","unstructured":"Camp JG, Sekine K, Gerber T, Loeffler-Wirth H, Binder H, Gac M, et al. Multilineage communication regulates human liver bud development from pluripotency. Nature. 2017;546(7659):533\u20138.","journal-title":"Nature"},{"issue":"4","key":"4334_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41592-022-01453-y","volume":"19","author":"Y Han","year":"2022","unstructured":"Han Y, Yang L, Lacko LA, Chen S. Human organoid models to study SARS-CoV-2 infection. Nat Methods. 2022;19(4):418\u201328.","journal-title":"Nat Methods"},{"issue":"4","key":"4334_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M Van de Wetering","year":"2015","unstructured":"Van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161(4):933\u201345.","journal-title":"Cell"},{"issue":"7459","key":"4334_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499(7459):481\u20134.","journal-title":"Nature"},{"issue":"18","key":"4334_CR20","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1242\/dev.118570","volume":"142","author":"M Huch","year":"2015","unstructured":"Huch M, Koo BK. Modeling mouse and human development using organoid cultures. Development. 2015;142(18):3113\u201325.","journal-title":"Development"},{"issue":"6096","key":"4334_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-\u2013RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816\u201321.","journal-title":"Science"},{"issue":"6121","key":"4334_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339(6121):819\u201323.","journal-title":"Science"},{"issue":"6","key":"4334_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262\u201378.","journal-title":"Cell"},{"issue":"5","key":"4334_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrg.2016.28","volume":"17","author":"SQ Tsai","year":"2016","unstructured":"Tsai SQ, Joung JK. Defining and improving the genome-wide specificities of CRISPR\u2013Cas9 nucleases. Nat Rev Genet. 2016;17(5):300\u201312.","journal-title":"Nat Rev Genet"},{"issue":"7587","key":"4334_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, et al. High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529(7587):490\u20135.","journal-title":"Nature"},{"issue":"7785","key":"4334_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576(7785):149\u201357.","journal-title":"Nature"},{"issue":"5","key":"4334_CR27","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152(5):1173\u201383.","journal-title":"Cell"},{"issue":"6271","key":"4334_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351(6271):400\u20133.","journal-title":"Science"},{"issue":"360","key":"4334_CR29","doi-asserted-by":"publisher","first-page":"360ra-134","DOI":"10.1126\/scitranslmed.aaf9336","volume":"8","author":"MA DeWitt","year":"2016","unstructured":"DeWitt MA, Magis W, Bray NL, Wang T, Berman JR, Urbinati F, et al. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells. Sci Transl Med. 2016;8(360):360ra\u2013134.","journal-title":"Sci Transl Med"},{"issue":"3","key":"4334_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, Chen YS, Domm J, Eustace BK, et al. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med. 2021;384(3):252\u201360.","journal-title":"N Engl J Med"},{"key":"4334_CR31","doi-asserted-by":"crossref","unstructured":"Dyer O., A Chinese researcher who made CRISPR babies, is sentenced to three years in prison. BMJ Br Med J Online. 2020;36811.","DOI":"10.1136\/bmj.m11"},{"issue":"22","key":"4334_CR32","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.3390\/ijms242216077","volume":"24","author":"M Tyumentseva","year":"2023","unstructured":"Tyumentseva M, Tyumentsev A, Akimkin V. CRISPR\/Cas9 landscape: Current state and future perspectives. Int J Mol Sci. 2023;24(22):16077.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4334_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/crispr.2020.29106.man","volume":"3","author":"M Angrist","year":"2020","unstructured":"Angrist M, Barrangou R, Baylis F, Brokowski C, Burgio G, Caplan A, et al. Reactions to the National Academies\/Royal Society report on heritable human genome editing. CRISPR J. 2020;3(5):332\u201349.","journal-title":"CRISPR J"},{"key":"4334_CR34","unstructured":"World Health Organization. Human genome editing: Recommendations. In: Human genome editing: recommendations. 2021."},{"issue":"7378","key":"4334_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature. 2011;480(7378):547\u201351.","journal-title":"Nature"},{"issue":"23","key":"4334_CR36","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, et al. Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20(23):4530\u20139.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"4334_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028420","volume":"6","author":"HE Marei","year":"2011","unstructured":"Marei HE, Althani A, Afifi N, Michetti F, Pescatori M, Pallini R, et al. Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. PLoS ONE. 2011;6(12): e28420.","journal-title":"PLoS ONE"},{"issue":"4","key":"4334_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033542","volume":"7","author":"HE Marei","year":"2012","unstructured":"Marei HE, Ahmed AE, Michetti F, Pescatori M, Pallini R, Casalbore P, et al. The gene expression profile of adult human olfactory bulbs and embryonic neural stem cells suggests distinct signaling pathways and epigenetic control. PLoS ONE. 2012;7(4): e33542.","journal-title":"PLoS ONE"},{"issue":"1","key":"4334_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jcp.24688","volume":"230","author":"HE Marei","year":"2015","unstructured":"Marei HE, Farag A, Althani A, Afifi N, Abd-Elmaksoud A, Lashen S, et al. Human olfactory bulb neural stem cells expressing hNGF restore cognitive deficit in Alzheimer\u2019s disease rat model. J Cell Physiol. 2015;230(1):116\u201330.","journal-title":"J Cell Physiol"},{"issue":"7","key":"4334_CR40","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/jcp.24909","volume":"230","author":"HE Marei","year":"2015","unstructured":"Marei HE, Lashen S, Farag A, Althani A, Afifi N, Rezk S, et al. Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson\u2019s disease. J Cell Physiol. 2015;230(7):1614\u201329.","journal-title":"J Cell Physiol"},{"issue":"4","key":"4334_CR41","first-page":"810","volume":"4","author":"MY Chen","year":"2024","unstructured":"Chen MY, Chi CY, Zheng CW, Wang CH, Chiu IM. Coordinated actions of neurogenesis and gliogenesis in nerve injury repair and neuroregeneration. Int J Transl Med. 2024;4(4):810\u201330.","journal-title":"Int J Transl Med"},{"issue":"22","key":"4334_CR42","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.scib.2023.10.020","volume":"68","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhao G. First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson\u2019s disease. Sci Bull. 2023;68(22):2700\u20133.","journal-title":"Sci Bull"},{"issue":"1","key":"4334_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders\u2014time for clinical translation? J Clin Investig. 2010;120(1):29\u201340.","journal-title":"J Clin Investig"},{"issue":"7","key":"4334_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/bioengineering10070857","volume":"10","author":"Z Wang","year":"2023","unstructured":"Wang Z. Assessing tumorigenicity in stem cell-derived therapeutic products: a critical step in safeguarding regenerative medicine. Bioengineering. 2023;10(7):857.","journal-title":"Bioengineering"},{"issue":"1","key":"4334_CR45","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","volume":"4","author":"S Petrus-Reurer","year":"2021","unstructured":"Petrus-Reurer S, Romano M, Howlett S, Jones JL, Lombardi G, Saeb-Parsy K. Immunological considerations and challenges for regenerative cellular therapies. Commun Biol. 2021;4(1):798.","journal-title":"Commun Biol"},{"key":"4334_CR46","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12015-020-10061-2","volume":"17","author":"P Pushp","year":"2021","unstructured":"Pushp P, Nogueira DE, Rodrigues CA, Ferreira FC, Cabral JM, Gupta MK. A concise review on induced pluripotent stem cell-derived cardiomyocytes for personalized regenerative medicine. Stem Cell Rev Rep. 2021;17:748\u201376.","journal-title":"Stem Cell Rev Rep"},{"key":"4334_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fneur.2017.00028","volume":"8","author":"A Hasan","year":"2017","unstructured":"Hasan A, Deeb G, Rahal R, Atwi K, Mondello S, Marei HE, et al. Mesenchymal stem cells in the treatment of traumatic brain injury. Front Neurol. 2017;8:28.","journal-title":"Front Neurol"},{"issue":"6","key":"4334_CR48","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","volume":"48","author":"P M\u00fcller","year":"2018","unstructured":"M\u00fcller P, Lemcke H, David R. Stem cell therapy in heart diseases\u2013cell types, mechanisms and improvement strategies. Cell Physiol Biochem. 2018;48(6):2607\u201355.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"4334_CR49","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","volume":"12","author":"JC Garbern","year":"2013","unstructured":"Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013;12(6):689\u201398.","journal-title":"Cell Stem Cell"},{"issue":"13","key":"4334_CR50","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/cells12131727","volume":"12","author":"CD Correia","year":"2023","unstructured":"Correia CD, Ferreira A, Fernandes MT, Silva BM, Esteves F, Leit\u00e3o HS, et al. Are we on the road to success for human stem cells for cardiac disease modeling and preclinical and clinical applications? Cells. 2023;12(13):1727.","journal-title":"Cells"},{"issue":"23","key":"4334_CR51","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61(23):2329\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4334_CR52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","volume":"15","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9 P. Cell therapy trials for heart regeneration\u2014lessons learned and future directions. Nat Rev Cardiol. 2018;15(11):659\u201371.","journal-title":"Nat Rev Cardiol"},{"issue":"36","key":"4334_CR53","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/eurheartj\/ehaa541","volume":"41","author":"RR Makkar","year":"2020","unstructured":"Makkar RR, Kereiakes DJ, Aguirre F, Kowalchuk G, Chakravarty T, Malliaras K, et al. Intracoronary ALLogeneic heart STem cells to Achieve Myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. Eur Heart J. 2020;41(36):3451\u20138.","journal-title":"Eur Heart J"},{"issue":"1","key":"4334_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4252\/wjsc.v9.i1.9","volume":"9","author":"S Der Sarkissian","year":"2017","unstructured":"Der Sarkissian S, L\u00e9vesque T, Noiseux N. Optimizing stem cells for cardiac repair: current status and new frontiers in regenerative cardiology. World J Stem Cells. 2017;9(1):9.","journal-title":"World J Stem Cells"},{"issue":"1","key":"4334_CR55","first-page":"12","volume":"10","author":"ZH Li","year":"2023","unstructured":"Li ZH, Wang J, Xu JP, Wang J, Yang X. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. Mil Med Res. 2023;10(1):12.","journal-title":"Mil Med Res"},{"key":"4334_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10439-016-1607-5","volume":"45","author":"B Duan","year":"2017","unstructured":"Duan B. State-of-the-art review of 3D bioprinting for cardiovascular tissue engineering. Ann Biomed Eng. 2017;45:195\u2013209.","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"4334_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ijmm.2016.2607","volume":"38","author":"R Sun","year":"2016","unstructured":"Sun R, Li X, Liu M, Zeng Y, Chen S, Zhang P. Advances in stem cell therapy for cardiovascular disease. Int J Mol Med. 2016;38(1):23\u20139.","journal-title":"Int J Mol Med"},{"issue":"9","key":"4334_CR58","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/nm912","volume":"9","author":"AA Mangi","year":"2003","unstructured":"Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore the performance of infarcted hearts. Nat Med. 2003;9(9):1195\u2013201.","journal-title":"Nat Med"},{"key":"4334_CR59","doi-asserted-by":"publisher","first-page":"1380443","DOI":"10.3389\/fendo.2024.1380443","volume":"15","author":"UE Habiba","year":"2024","unstructured":"Habiba UE, Khan N, Greene DL, Ahmad K, Shamim S, Umer A. Meta-analysis shows that mesenchymal stem cell therapy can be a possible diabetes treatment. Front Endocrinol. 2024;15:1380443.","journal-title":"Front Endocrinol"},{"issue":"1","key":"4334_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen W, Feng B, Cao H. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis. Aging Dis. 2020;11(1):141.","journal-title":"Aging Dis"},{"key":"4334_CR61","doi-asserted-by":"crossref","unstructured":"Luo Y, Yu P, Liu J. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent Advances and current challenges. Endocrine. 2024;1\u201314.","DOI":"10.1007\/s12020-024-03855-8"},{"issue":"8","key":"4334_CR62","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"Carlsson PO, Espes D, Sisay S, Davies LC, Smith CE, Svahn MG. Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a phase I\/II randomized double-blind placebo-controlled trial. Diabetologia. 2023;66(8):1431\u201341.","journal-title":"Diabetologia"},{"issue":"5","key":"4334_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103058","volume":"21","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Knight CM, Jiang Z, Delgado E, Van Hoven AM, Ghanny S, et al. Stem Cell Educator therapy in type 1 diabetes: from the bench to clinical trials. Autoimmun Rev. 2022;21(5): 103058.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4334_CR64","first-page":"1286054","volume":"2019","author":"A Kaur","year":"2019","unstructured":"Kaur A, Midha S, Giri S, Mohanty S. Functional skin grafts: where biomaterials meet stem cells. Stem Cells Int. 2019;2019(1):1286054.","journal-title":"Stem Cells Int"},{"issue":"8","key":"4334_CR65","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s13238-015-0180-2","volume":"6","author":"C Hu","year":"2015","unstructured":"Hu C, Li L. In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration. Protein Cell. 2015;6(8):562\u201374.","journal-title":"Protein Cell"},{"issue":"7","key":"4334_CR66","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17476348.2019.1624163","volume":"13","author":"SD Skolasinski","year":"2019","unstructured":"Skolasinski SD, Panoskaltsis-Mortari A. Lung tissue bioengineering for chronic obstructive pulmonary disease: overcoming the need for lung transplantation from human donors. Expert Rev Respir Med. 2019;13(7):665\u201378.","journal-title":"Expert Rev Respir Med"},{"key":"4334_CR67","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jrhm.2016.09.002","volume":"2","author":"D Ghosh","year":"2016","unstructured":"Ghosh D, Mehta N, Patil A, Sengupta J. Ethical issues in human embryonic stem cells (hESCs) biomedical use. J Reprod Health Med. 2016;2:S37-47.","journal-title":"J Reprod Health Med"},{"issue":"3","key":"4334_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13770-024-00627-3","volume":"21","author":"SJ Park","year":"2024","unstructured":"Park SJ, Kim YY, Han JY, Kim SW, Kim H, Ku SY. Advancements in human embryonic stem cell research: clinical applications and ethical issues. Tissue Eng Regen Med. 2024;21(3):379\u201394.","journal-title":"Tissue Eng Regen Med"},{"issue":"3","key":"4334_CR69","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/er.2008-0031","volume":"30","author":"B Lo","year":"2009","unstructured":"Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30(3):204\u201313.","journal-title":"Endocr Rev"},{"issue":"3","key":"4334_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/CRD.0000000000000018","volume":"22","author":"RE Michler","year":"2014","unstructured":"Michler RE. Stem cell therapy for heart failure. Cardiol Rev. 2014;22(3):105\u201316.","journal-title":"Cardiol Rev"},{"issue":"7","key":"4334_CR71","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23(7):845\u201356.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4334_CR72","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"key":"4334_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-29","volume":"9","author":"CA Herberts","year":"2011","unstructured":"Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9:1\u201314.","journal-title":"J Transl Med"},{"key":"4334_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt474","volume":"5","author":"NM King","year":"2014","unstructured":"King NM, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther. 2014;5:1\u20136.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4334_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/10383441.2024.2422138","volume":"33","author":"L Langford","year":"2024","unstructured":"Langford L, Foong P. Unproven stem cell therapies: evaluating patients\u2019 capacity to give informed consent. Griffith Law Rev. 2024;33(1):58\u201388.","journal-title":"Griffith Law Rev"},{"issue":"5935","key":"4334_CR76","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1173712","volume":"324","author":"DW Fink Jr","year":"2009","unstructured":"Fink DW Jr. FDA regulation of stem cell-based products. Science. 2009;324(5935):1662\u20133.","journal-title":"Science"},{"issue":"5","key":"4334_CR77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.molmed.2015.02.008","volume":"21","author":"L Turner","year":"2015","unstructured":"Turner L. US stem cell clinics, patient safety, and the FDA. Trends Mol Med. 2015;21(5):271\u20133.","journal-title":"Trends Mol Med"},{"issue":"4","key":"4334_CR78","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.stemcr.2018.08.013","volume":"11","author":"V Volpato","year":"2018","unstructured":"Volpato V, Smith J, Sandor C, Ried JS, Baud A, Handel A, et al. Reproducibility of molecular phenotypes after long-term differentiation to human iPSC-derived neurons: a multi-site omics study. Stem cell Rep. 2018;11(4):897\u2013911.","journal-title":"Stem cell Rep"},{"key":"4334_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155354","volume":"260","author":"Z Lyu","year":"2024","unstructured":"Lyu Z, Xin M, Oyston DR, Xue T, Kang H, Wang X, et al. Cause and consequence of heterogeneity in human mesenchymal stem cells: challenges in clinical application. Pathol Res Pract. 2024;260: 155354.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"4334_CR80","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111(3):344\u201358.","journal-title":"Circ Res"},{"issue":"16","key":"4334_CR81","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1056\/NEJMhpr063086","volume":"355","author":"DG Halme","year":"2006","unstructured":"Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N Engl J Med. 2006;355(16):1730.","journal-title":"N Engl J Med"},{"key":"4334_CR82","doi-asserted-by":"crossref","unstructured":"Seet WT, Mat Afandi MA, Shamsuddin SA, Lokanathan Y, Ng MH, Maarof M. Current good manufacturing practice (cGMP) Facility and stem cell production. In: Stem Cell Production: Processes, Practices and Regulations. Springer; 2022. p. 37\u201368.","DOI":"10.1007\/978-981-16-7589-8_3"},{"key":"4334_CR83","doi-asserted-by":"crossref","unstructured":"Aly RM. The current state of stem cell-based therapies: an overview. Stem Cell Investig. 2020;7.","DOI":"10.21037\/sci-2020-001"},{"issue":"1","key":"4334_CR84","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-024-03891-1","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Cho HJ, Han Y, Lee SH. Mid-to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis. Stem Cell Res Ther. 2024;15(1):290.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4334_CR85","first-page":"310","volume":"12","author":"M Bahari","year":"2023","unstructured":"Bahari M, Mokhtari H, Yeganeh F. Stem cell therapy, the market, the opportunities and the threat. Int J Mol Cell Med. 2023;12(3):310.","journal-title":"Int J Mol Cell Med"},{"issue":"278","key":"4334_CR86","doi-asserted-by":"publisher","first-page":"278ps4","DOI":"10.1126\/scitranslmed.3010496","volume":"7","author":"K Kamenova","year":"2015","unstructured":"Kamenova K, Caulfield T. Stem cell hype: media portrayal of therapy translation. Sci Transl Med. 2015;7(278):278ps4.","journal-title":"Sci Transl Med"},{"key":"4334_CR87","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.reth.2023.07.009","volume":"24","author":"K Takashima","year":"2023","unstructured":"Takashima K, Minari J, Chan S, Muto K. Hope for the best, but prepare for the worst: Social media posted by participants in stem cell clinical trials. Regen Ther. 2023;24:294\u20137.","journal-title":"Regen Ther"},{"key":"4334_CR88","doi-asserted-by":"crossref","unstructured":"BS S, Chua K, Tan B. Ensuring Safety in Stem Cell Therapies: A Review of Tumorigenic Risks and Mitigation Strategies. 2024.","DOI":"10.20944\/preprints202409.0136.v1"},{"issue":"2","key":"4334_CR89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/stcltm\/szab020","volume":"11","author":"\u00c9 Mezey","year":"2022","unstructured":"Mezey \u00c9. Human mesenchymal stem\/stromal cells in immune regulation and therapy. Stem Cells Transl Med. 2022;11(2):114\u201334.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"4334_CR90","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/cells10061470","volume":"10","author":"G Sessa","year":"2021","unstructured":"Sessa G, Adami R, Bottai D. iPSC preparation and epigenetic memory: Does the tissue origin matter? Cells. 2021;10(6):1470.","journal-title":"Cells"},{"issue":"7","key":"4334_CR91","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/0192623320918241","volume":"49","author":"R Haworth","year":"2021","unstructured":"Haworth R, Sharpe M. Accept or reject: the role of immune tolerance in developing stem cell therapies and possible future approaches. Toxicol Pathol. 2021;49(7):1308\u201316.","journal-title":"Toxicol Pathol"},{"key":"4334_CR92","doi-asserted-by":"crossref","unstructured":"Singh B. Cutting Edges in Human Germline Editing Reconciling Scientific Progress With Rogues and Legal Framework: Global Observatory Its Inherent Conundrums. In: Ethical Dimensions of AI Development. IGI Global; 2025. p. 227\u201350.","DOI":"10.4018\/979-8-3693-4147-6.ch010"},{"issue":"1","key":"4334_CR93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1353\/pbm.2020.0003","volume":"63","author":"K Doxzen","year":"2020","unstructured":"Doxzen K, Halpern J. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation. Perspect Biol Med. 2020;63(1):44\u201353.","journal-title":"Perspect Biol Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04334-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:04:21Z","timestamp":1747908261000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04334-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the review was conducted without any commercial or financial relationships that could create a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}